SIG
44
-2
TRIP
58
9
CVX
34
2
SLB
56
3
AMP
64
-3
ACN
54
-2
ROK
44
-2
TSN
50
2
BRK.B
47
2
NAVI
32
2
ILMN
68
-2
AAP
8
2
COF
63
-2
MSI
50
3
GILD
54
-2
KMX
40
2
GD
59
-3
MS
74
-2
HCA
62
-2
EMN
58
2
SIG
44
-2
TRIP
58
9
CVX
34
2
SLB
56
3
AMP
64
-3
ACN
54
-2
ROK
44
-2
TSN
50
2
BRK.B
47
2
NAVI
32
2
ILMN
68
-2
AAP
8
2
COF
63
-2
MSI
50
3
GILD
54
-2
KMX
40
2
GD
59
-3
MS
74
-2
HCA
62
-2
EMN
58
2
Financhill
Back

State Street SPDR S&P Biotech ETF Vs. Corcept Therapeutics, Inc. Industry Stock Comparison

Buy
62

XBI
State Street SPDR S&P Biotech ETF

Last Price:
$121.64
Seasonality Move:
0.43%
Sell
36

CORT
Corcept Therapeutics, Inc.

Last Price:
$35.90
Seasonality Move:
6.8%
Buy
62
State Street SPDR S&P Biotech ETF (XBI) is a Buy

Is State Street SPDR S&P Biotech ETF a Buy, Sell or Hold?

  • The current State Street SPDR S&P Biotech ETF [XBI] share price is $121.67. The Score for XBI is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • XBI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Corcept Therapeutics, Inc. (CORT) is a Sell

Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Corcept Therapeutics, Inc. [CORT] share price is $70.20. The Score for CORT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CORT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XBI Stock Price Chart

What is State Street SPDR S&P Biotech ETF's stock price today?

  • The State Street SPDR S&P Biotech ETF share price today is $121.67
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XBI is experiencing selling pressure, which indicates risk of future bearish movement.

CORT Stock Price Chart

What is Corcept Therapeutics, Inc.'s stock price today?

  • The Corcept Therapeutics, Inc. share price today is $70.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.

XBI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 34.29 Buy
Relative Strength Index (14 RSI): 51.57 Buy
Chaikin Money Flow: -5330639 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (120.06 - 124.34) Sell
Bollinger Bands (100): (93.57 - 118.33) Buy

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 32.16 Sell
Chaikin Money Flow: -2244663 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (78.7 - 85.94) Sell
Bollinger Bands (100): (71.38 - 83.18) Sell

XBI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 123.33 Sell
20-day SMA: 122.57 Sell
50-day SMA: 116.65 Buy
200-day SMA: 94.11 Buy
8-day EMA: 106.95 Buy
20-day EMA: 68.02 Buy
50-day EMA: 33.79 Buy
200-day EMA: 9.48 Buy

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 81.08 Sell
20-day SMA: 83.06 Sell
50-day SMA: 78.49 Sell
200-day SMA: 74.04 Sell
8-day EMA: 79.79 Sell
20-day EMA: 81.21 Sell
50-day EMA: 78.92 Sell
200-day EMA: 51.36 Buy

State Street SPDR S&P Biotech ETF Earnings Growth & XBI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $3.11 per share.

State Street SPDR S&P Biotech ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):